The updated guidelines recommend that people keep their systolic blood pressure under a specific number — 130 — to prevent ...

In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...

What you need to know ### BMJ Learning To obtain accredited continuous professional development points, subscribers to BMJ Learning can complete the full module at The module contains four additional ...

ZOLL also pioneered the use of artificial intelligence in WCDs, introducing an AI-enhanced algorithm in 2018 that reduced false alarms to a median of zero at 90 days.³ The latest generation LifeVest ...

Asahi Kasei announced that ZOLL® Medical, an Asahi Kasei company, has launched the next-generation LifeVest® wearable ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for dermatology, hematology, and infectious & inflammatory diseases, announced today ...

Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, announced a strategic collaboration with Polyphron, a company developing an autonomous ...

Black and Latino people are less likely than white people to be prescribed GLP-1s for diabetes. Here's what studies reveal.

Pharmacists warn that common OTC meds can interfere with heart prescriptions. Avoid dangerous interactions with NSAIDs, ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

Cambridge researchers have discovered that an existing therapy which boosts protective immune cells in people who recently ...

Researchers developed an AI model to detect myocardial ischemia and coronary microvascular and vasomotor dysfunction using ...